• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease.量表提供了识别非酒精性脂肪性肝病患者生活方式干预依从性的可能性。
World J Gastroenterol. 2024 Jul 7;30(25):3179-3181. doi: 10.3748/wjg.v30.i25.3179.
2
Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need.非酒精性脂肪性肝病患者自我管理的定量评估：未满足的临床需求。
World J Gastroenterol. 2024 Jul 7;30(25):3143-3146. doi: 10.3748/wjg.v30.i25.3143.
3
Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease.非酒精性脂肪性肝病生活方式干预依从性预测系统的验证。
World J Gastroenterol. 2024 May 28;30(20):2629-2632. doi: 10.3748/wjg.v30.i20.2629.
4
Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease.生活方式干预对非酒精性脂肪性肝病发病机制的影响。
World J Gastroenterol. 2024 May 28;30(20):2633-2637. doi: 10.3748/wjg.v30.i20.2633.
5
Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease.建立和验证非酒精性脂肪性肝病生活方式干预依从性预测系统。
World J Gastroenterol. 2024 Mar 14;30(10):1393-1404. doi: 10.3748/wjg.v30.i10.1393.
6
Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.基于地中海生活方式的干预对非酒精性脂肪性肝病患者临床特征的改善：一项随机对照临床试验。
Br J Nutr. 2018 Jul;120(2):164-175. doi: 10.1017/S000711451800137X.
7
Management of non-alcoholic fatty liver disease: Lifestyle changes.非酒精性脂肪性肝病的管理：生活方式的改变。
World J Gastroenterol. 2024 Jun 14;30(22):2829-2833. doi: 10.3748/wjg.v30.i22.2829.
8
Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病管理中的生活方式与饮食干预
Dig Dis Sci. 2016 May;61(5):1365-74. doi: 10.1007/s10620-016-4153-y.
9
Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.非酒精性脂肪肝和非酒精性脂肪性肝炎的生活方式改变。
Curr Vasc Pharmacol. 2018;16(3):239-245. doi: 10.2174/1570161115666170621080835.
10
Role of diet and lifestyle changes in nonalcoholic fatty liver disease.饮食和生活方式改变在非酒精性脂肪性肝病中的作用。
World J Gastroenterol. 2014 Jul 28;20(28):9338-44. doi: 10.3748/wjg.v20.i28.9338.

本文引用的文献

1
Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease.建立和验证非酒精性脂肪性肝病生活方式干预依从性预测系统。
World J Gastroenterol. 2024 Mar 14;30(10):1393-1404. doi: 10.3748/wjg.v30.i10.1393.
2
AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.AGA 临床实践更新：瘦个体中非酒精性脂肪性肝病的诊断和管理：专家评论。
Gastroenterology. 2022 Sep;163(3):764-774.e1. doi: 10.1053/j.gastro.2022.06.023. Epub 2022 Jul 14.
3
Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss.非酒精性脂肪性肝病（NAFLD）：病理生理学、临床管理和减肥效果的综述。
BMC Endocr Disord. 2022 Mar 14;22(1):63. doi: 10.1186/s12902-022-00980-1.
4
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21.
5
Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease.亚洲非酒精性脂肪性肝病患者的不健康生活方式习惯及缺乏身体活动情况。
Liver Int. 2020 Nov;40(11):2719-2731. doi: 10.1111/liv.14638. Epub 2020 Oct 13.
6
Treatment of NAFLD with diet, physical activity and exercise.非酒精性脂肪性肝病的饮食、身体活动和运动治疗。
J Hepatol. 2017 Oct;67(4):829-846. doi: 10.1016/j.jhep.2017.05.016. Epub 2017 May 23.
7
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病
BMC Med. 2017 Feb 28;15(1):45. doi: 10.1186/s12916-017-0806-8.
8
Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease.非酒精性脂肪性肝病的改变阶段和更健康生活方式的动机。
J Hepatol. 2013 Apr;58(4):771-7. doi: 10.1016/j.jhep.2012.11.031. Epub 2012 Nov 29.

量表提供了识别非酒精性脂肪性肝病患者生活方式干预依从性的可能性。

Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease.

机构信息

Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.

Department of Gastroenterology and Hepatology/Medical Engineering Integration Laboratory of Digestive Endoscopy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.

出版信息

World J Gastroenterol. 2024 Jul 7;30(25):3179-3181. doi: 10.3748/wjg.v30.i25.3179.

DOI:10.3748/wjg.v30.i25.3179
PMID:39006387
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11238675/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder, and dietary and lifestyle interventions remain the mainstays of NAFLD therapy. Zeng established a prediction system to evaluate adherence to lifestyle interventions in patients with NAFLD and choose optimal management. Here, we discuss the application scenarios of the scale and the areas warranting further attention, aiming to provide a possible reference for clinical recommendations.

摘要

非酒精性脂肪性肝病 (NAFLD) 是最常见的慢性肝脏疾病，饮食和生活方式干预仍然是 NAFLD 治疗的主要方法。曾建立了一个预测系统来评估 NAFLD 患者对生活方式干预的依从性，并选择最佳管理方案。在这里，我们讨论了该量表的应用场景和需要进一步关注的领域，旨在为临床推荐提供可能的参考。